Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts

作者: Kimford Meador , Matthew W. Reynolds , Sheila Crean , Kyle Fahrbach , Corey Probst

DOI: 10.1016/J.EPLEPSYRES.2008.04.022

关键词:

摘要: Summary Purpose To conduct a systematic review and meta-analysis to quantify the incidence of congenital malformations (CMs) other pregnancy outcomes as function in utero anti-epileptic drug (AED) exposure. Methods We performed literature identify all published registries cohort studies births from pregnant women with epilepsy (WWE) that reported CMs. Overall incidences were calculated using random effects model. Results The included 59 met inclusion/exclusion criteria, involving 65,533 pregnancies WWE 1,817,024 healthy women. CM [7.08%; 95% CIs 5.62, 8.54] was higher than [2.28%; 1.46, 3.10]. Incidence highest for AED polytherapy [16.78%; 0.51, 33.05]. valproate, which 10.73% [CIs 8.16, 13.29] valproate monotherapy. Conclusions this suggest overall CMs children born is approximately threefold risk elevated monotherapy further compared without epilepsy. significantly exposed 2 or more drugs when combination phenobarital, phenytoin, valproate. Further research needed delineate specific each individual determine underlying mechanisms including genetic factors.

参考文章(101)
A Magaudda, P Genton, R Guerrini, C Julian, N Giraud, C Legras, G Trentin, S Soulayrol, C Dravet, E Mesdjian, Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology. ,vol. 42, pp. 75- 82 ,(1992)
L Pijpers, H Brandenburg, J G Omtzigt, H L Gaillard, J W Wladimiroff, E S Sachs, P A Stewart, M G Jahoda, D E Grobbee, F J Los, The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort Neurology. ,vol. 42, pp. 119- 125 ,(1992)
Susan S. Jick, Barbara Z. Terris, Anticonvulsants and Congenital Malformations Pharmacotherapy. ,vol. 17, pp. 561- 564 ,(1997) , 10.1002/J.1875-9114.1997.TB03065.X
V.K. Hiilesmaa, K. Teramo, M.-L. Granström, A.H. Bardy, FETAL HEAD GROWTH RETARDATION ASSOCIATED WITH MATERNAL ANTIEPILEPTIC DRUGS The Lancet. ,vol. 318, pp. 165- 167 ,(1981) , 10.1016/S0140-6736(81)90354-8
Y Fukushima, R Kan, A Takeda, Y Nakane, Y Ogawa, L Dansky, M Oguni, I Lopez-Ciendas, A Sherwin, F Andermann, M.-H Seni, K Otani, T Teranishi, M Goto, D Battino, S Kaneko, E Andermann, G Avanzini, M.P Canevini, R Canger, D Croci, C Fumarola, L Guidolin, D Mamoli, F Molteni, G Pardi, A Vignoli, Intrauterine growth in the offspring of epileptic women : a prospective multicenter study Epilepsy Research. ,vol. 36, pp. 53- 60 ,(1999) , 10.1016/S0920-1211(99)00020-0
Anders Dejgard, Palle Petersen, Jens Kastrup, Mexiletine for treatment of chronic painful diabetic neuropathy The Lancet. ,vol. 1, pp. 9- 11 ,(1988) , 10.1016/S0140-6736(88)90999-3
P.J. Martin, P.A.H. Millac, Pregnancy, epilepsy, management and outcome: a 10-year perspective Seizure-european Journal of Epilepsy. ,vol. 2, pp. 277- 280 ,(1993) , 10.1016/S1059-1311(05)80140-2
J.D. Niswander, W. Wertelecki, Congenital malformation among offspring of epileptic women. The Lancet. ,vol. 301, pp. 1062- ,(1973) , 10.1016/S0140-6736(73)90699-5